MISSISSAUGA, Ontario–(BUSINESS WIRE)–MedX Health Corporation (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that Sylvain Desjeans has been appointed as the Company’s President and Chief Executive Officer, effective immediately. With more than 30 years of health-care and pharmaceutical industry experience, Mr. Desjeans served in successively senior roles at organizations such as Aspen Pharmacare Canada, Accucaps Industries Limited and Biovail